Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/2005
09/09/2005WO2005082418A1 Long-acting solid formulation comprising triptorelin acetate
09/09/2005WO2005082415A2 Inhibitors of insulin-like growth factor receptor-1 for inhibiting tumor cell growth
09/09/2005WO2005082406A1 Lactalbumin for inhibiting angiogenesis
09/09/2005WO2005082405A1 Protein drug sustained-release microparticle preparation for injection and process for producing the same
09/09/2005WO2005082404A2 Glp-2 derivatives modified by lipophilic substituents
09/09/2005WO2005082403A1 Use of neuropeptides for ligament healing
09/09/2005WO2005082402A1 Preventive/therapeutic agent for organ fibrosis
09/09/2005WO2005082401A1 Methods of treating obesity or diabetes using nt-4/5
09/09/2005WO2005082399A2 Treatment of bacterial infections
09/09/2005WO2005082398A2 Diagnosis of hyperinsulinemia and type ii diabetes and protection against same based on genes differentially expressed in muscle cells
09/09/2005WO2005082397A1 Combinatorial therapies for the treatment of neoplasias using the opioid growth factor receptor
09/09/2005WO2005082396A2 Use of mda-7 to inhibit infection by pathogenic organisms
09/09/2005WO2005082395A1 Novel hair growth stimulant and anti-alopecia agent
09/09/2005WO2005082394A1 Phosphorylation inhibitors for insulin receptor
09/09/2005WO2005082389A1 Cancer metastasis inhibitory composition
09/09/2005WO2005082386A2 Manganese and iron based compounds for elastogenesis and connective tissue treatment
09/09/2005WO2005082377A1 INHIBITOR FOR LOWERING IN THE ACTIVITY OF ANTIHUMAN TNF-α ANTIBODY
09/09/2005WO2005082348A2 Inhibitors of dipeptidylpeptidase iv for regulating glucose metabolism
09/09/2005WO2005082339A2 Medicaments and methods for treating headache
09/09/2005WO2005082080A2 Method to modulate the immune system with a novel guanine nucleotide exchange factor
09/09/2005WO2005082076A2 Methods for treating breast cancer using nrif3 related molecules
09/09/2005WO2005082070A2 Compositions and methods for the systemic treatment of arthritis
09/09/2005WO2005082042A2 Therapeutic methods employing nitric oxide precursors
09/09/2005WO2005082023A2 Heterocyclic self-immolative linkers and conjugates
09/09/2005WO2005081873A2 Il-13 mutein proteins, antibodies, compositions, methods and uses
09/09/2005WO2005081858A2 Parkin-associated complex for protecting post-mitotic neurons from excitotoxicity and uses thereof
09/09/2005WO2005081816A2 Method of preventing fibrin clots in pulmonary tissue through the use of aerosolized anticoagulants
09/09/2005WO2005081711A2 Monomethylvaline compounds capable of conjugation to ligands
09/09/2005WO2005081649A2 Preparation for reducing protein deficiency in an organism and method for the production thereof
09/09/2005WO2005081619A2 Compounds and methods for increasing neurogenesis
09/09/2005WO2005081613A2 Pharmaceutical compositions of peptides secreted by the venom glands of snakes
09/09/2005WO2005072700A3 Haemostatic sprays and compositions
09/09/2005WO2005067956A3 Use of interleukin-21 for the treatment of autoimune diseases and allograft rejection
09/09/2005WO2005065722A3 Reducing arthritis and lameness in subjects by growth hormone releasing hormone (ghrh) supplementation
09/09/2005WO2005060997A3 Medicament comprising inhibitors of long pentraxin ptx3
09/09/2005WO2005056036A3 Regulation of food preference using glp-1 agonists
09/09/2005WO2005051994A3 Ztnf11, a tumor necrosis factor
09/09/2005WO2005051410B1 Hepatitis c virus inhibitors
09/09/2005WO2005046708A8 Selective inhibitors of nuclear factor-kb activation and uses thereof
09/09/2005WO2005044192A3 Triazole compounds and uses related thereto
09/09/2005WO2005042031A3 Oligoribonucleotides for the treatment of undesired skin and hair pigmentation due to rna interference
09/09/2005WO2005034733A3 Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia
09/09/2005WO2005030802A3 Antigens for an east coast fever vaccine
09/09/2005WO2005030797A3 Melanocortin receptor agonists
09/09/2005WO2005026362A3 Lymphatic and blood endothelial cell genes
09/09/2005WO2005020984A3 Method of reducing the risk of oxidative stress
09/09/2005WO2005011725A3 Anti-angiogenetic agent and its use, in particular in cancer treatment
09/09/2005WO2005009287A3 Drug delivery to the inner ear and methods of using same
09/09/2005WO2005007804A3 Anthrax conjugate vaccine and antibodies
09/09/2005WO2005007122A3 Polymer stabilization
09/09/2005WO2005002526A3 Method and compositions for treatment of viral infections
09/09/2005WO2005000882A3 Dna fragments and proteins encoded by said dna isolated from bifidobacteria
09/09/2005WO2005000198A3 An intracellular estradiol binding protein, a polynucleotide encoding the same and cell lines overexpressing the same
09/09/2005WO2004113513A3 Methods and compositions for modulating stem cell growth and differentiation
09/09/2005WO2004112763A3 Inhibition of protein kinase c-mu (pkd) as a treatment for cardiac hypertrophy and heart failure
09/09/2005WO2004112691A3 Interferon gamma therapies for idiopathic pulmonary fibrosis
09/09/2005WO2004111090A3 Molecules for targeting and releasing therapeutic compounds, and the use thereof
09/09/2005WO2004110341A3 Antimicrobial and anticancer lipopeptides
09/09/2005WO2004101597A3 Methods for the reduction of disulfide bonds
09/09/2005WO2004100879A3 Method and composition for preventing or reducing edema, deep vein thrombosis and/or pulmonary embolism
09/09/2005WO2004096144A3 Compositions and methods for induction of opioid receptors
09/09/2005WO2004080482A8 Use of angiotensin converting enzyme (ace) inhibitors to prevent diabetes in a subject with chronic heart failure
09/09/2005WO2004078981A8 Hyperactive, non-phosphorylated, mutant transposases of mariner mobile genetic elements
09/09/2005WO2004078925A3 Methods and compositions for treating and preventing neurodegenerative diseases
09/09/2005WO2004076635A3 Therapeutic applications of thrombomodulin gene via viral and non-viral vectors
09/09/2005WO2004060081A8 A method of improving nutrient utilisation by a mammal and a composition for use therein
09/09/2005WO2004054433A3 Forming iron nitrosyl hemoglobin
09/09/2005WO2004046169A8 Activation of peptide prodrugs by hk2
09/09/2005WO2003093421A3 Methods and compositions for use in homologous recombination
09/09/2005WO2003086284A3 Colon tumor specific binding peptides
09/09/2005WO2003057854A3 Novel proteins and nucleic acids encoding same
09/09/2005CA2846382A1 Iron based compounds for elastogenesis and connective tissue treatment
09/09/2005CA2841741A1 Monomethylvaline compounds capable of conjugation to ligands
09/09/2005CA2599304A1 Cell targeting conjugates
09/09/2005CA2575416A1 Bone sialoprotein collagen-binding peptides
09/09/2005CA2562871A1 Iron based compounds for elastogenesis and connective tissue treatment
09/09/2005CA2559415A1 Methods for obtaining thermostable enzymes, dna polymerase i variants from thermus aquaticus having new catalytic activities, methods for obtaining the same, and applications of the same
09/09/2005CA2558178A1 Recombinant perforin, expression and uses thereof
09/09/2005CA2558155A1 Casein derived peptides and therapeutic uses thereof
09/09/2005CA2558106A1 Inhibitors of dipeptidylpeptidase iv for regulating glucose metabolism
09/09/2005CA2557597A1 A novel cofactor that modulates steroid receptor activities
09/09/2005CA2557588A1 Medicaments and methods for treating headache
09/09/2005CA2557508A1 Compositions and methods for the systemic treatment of arthritis
09/09/2005CA2557504A1 Combinatorial therapies for the treatment of neoplasias using the opioid growth factor receptor
09/09/2005CA2557500A1 Methods and compositions for the treatment and prevention of hiv infection using trim5.alpha.
09/09/2005CA2557499A1 Il-13 mutein proteins, antibodies, compositions, methods and uses
09/09/2005CA2557411A1 Method of preventing fibrin clots in pulmonary tissue through the use of aerosolized anticoagulants
09/09/2005CA2557397A1 Protein drug sustained-release microparticle preparation for injection and process for producing the same
09/09/2005CA2557326A1 Combination of ad-p53 and chemotherapy for the treatment of tumours
09/09/2005CA2557181A1 Diagnosis of hyperinsulinemia and type ii diabetes and protection against same based on genes differentially expressed in muscle cells
09/09/2005CA2557151A1 Peptide analogues of gip for treatment of diabetes, insulin resistance and obesity
09/09/2005CA2556923A1 Methods of treating obesity or diabetes using nt-4/5
09/09/2005CA2556893A1 Antihypertensive peptides
09/09/2005CA2556832A1 Binding peptidomimetics and uses of the same
09/09/2005CA2556830A1 Methods and compositions comprising non-peptide small molecules that solubilize beta amyloid peptide fiber
09/09/2005CA2556752A1 Heterocyclic self-immolative linkers and conjugates
09/09/2005CA2556632A1 Egf receptor epitope peptides and uses thereof
09/09/2005CA2556479A1 Methods and compositions comprising supramolecular constructs
09/09/2005CA2556104A1 Diagnosis or treatment of endothelial cell dysfunction related diseases
09/09/2005CA2555583A1 Positive modulator of bone morphogenic protein-2
1 ... 1383 1384 1385 1386 1387 1388 1389 1390 1391 1392 1393 1394 1395 1396 1397 1398 1399 1400 1401 1402 1403 ... 3163